{"id":"https://openalex.org/W2323716522","doi":"https://doi.org/10.1097/01.qai.0000456200.40808.06","title":"P-D11 Structural basis for ADCC to A32-like region","display_name":"P-D11 Structural basis for ADCC to A32-like region","publication_year":2014,"publication_date":"2014-10-18","ids":{"openalex":"https://openalex.org/W2323716522","doi":"https://doi.org/10.1097/01.qai.0000456200.40808.06","mag":"2323716522"},"language":"en","primary_location":{"id":"doi:10.1097/01.qai.0000456200.40808.06","doi":"https://doi.org/10.1097/01.qai.0000456200.40808.06","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.qai.0000456200.40808.06","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060152195","display_name":"William David Tolbert","orcid":"https://orcid.org/0000-0001-7549-9596","observed_orcids":["https://orcid.org/0000-0001-7549-9596"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Tolbert","raw_affiliation_strings":["Institute of Human Virology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Human Virology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064884096","display_name":"Neelakshi Gohain","orcid":"https://orcid.org/0000-0003-1370-312X","observed_orcids":["https://orcid.org/0000-0003-1370-312X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neelakshi Gohain","raw_affiliation_strings":["IHV"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IHV","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000868484","display_name":"Priyamvada Acharya","orcid":"https://orcid.org/0000-0002-0089-277X","observed_orcids":["https://orcid.org/0000-0002-0089-277X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Priyamvada Acharya","raw_affiliation_strings":["NIH/VRC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIH/VRC","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021374249","display_name":"Roberta Kamin\u2010Lewis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roberta Kamin-Lewis","raw_affiliation_strings":["IHV"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IHV","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029421916","display_name":"Lo\u0131\u0308c Martin","orcid":"https://orcid.org/0000-0002-7940-2955","observed_orcids":["https://orcid.org/0000-0002-7940-2955"]},"institutions":[{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210152344","display_name":"Institut de Biologie et Technologies","ror":"https://ror.org/052wcqj17","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210152344"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Loic Martin","raw_affiliation_strings":["CEA, iBiTecS, Service d'Ingenierie Moleculaire des Proteines"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEA, iBiTecS, Service d'Ingenierie Moleculaire des Proteines","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210152344"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043677118","display_name":"Peter D. Kwong","orcid":"https://orcid.org/0000-0003-3560-232X","observed_orcids":["https://orcid.org/0000-0003-3560-232X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Kwong","raw_affiliation_strings":["NIH/VRC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIH/VRC","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051639363","display_name":"Yongjun Guan","orcid":"https://orcid.org/0000-0001-6546-2095","observed_orcids":["https://orcid.org/0000-0001-6546-2095"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yongjun Guan","raw_affiliation_strings":["IHV"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IHV","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030545878","display_name":"Anthony L. DeVico","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony DeVico","raw_affiliation_strings":["IHV"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IHV","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040770925","display_name":"George K. Lewis","orcid":"https://orcid.org/0000-0003-4815-2604","observed_orcids":["https://orcid.org/0000-0003-4815-2604"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George Lewis","raw_affiliation_strings":["IHV"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IHV","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043383923","display_name":"Marzena Pazgier","orcid":"https://orcid.org/0000-0003-0594-5057","observed_orcids":["https://orcid.org/0000-0003-0594-5057"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marzena Pazgier","raw_affiliation_strings":["Institute of Human Virology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Human Virology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"67","issue":"Supplement 3","first_page":"92","last_page":"92"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.972000002861023},{"id":"https://openalex.org/keywords/hiv-1-envelope-glycoprotein","display_name":"HIV-1 envelope glycoprotein","score":0.8140000104904175},{"id":"https://openalex.org/keywords/gp120","display_name":"gp120","score":0.8939999938011169},{"id":"https://openalex.org/keywords/crystal-structure","display_name":"crystal structure","score":0.796999990940094},{"id":"https://openalex.org/keywords/hiv-1-vaccine-design","display_name":"HIV-1 vaccine design","score":0.7390000224113464},{"id":"https://openalex.org/keywords/hiv-1-env-trimer","display_name":"HIV-1 Env trimer","score":0.6600000262260437},{"id":"https://openalex.org/keywords/cd4-binding","display_name":"CD4 binding","score":0.47699999809265137}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.8963581323623657},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.8189396858215332},{"id":"https://openalex.org/C2776258796","wikidata":"https://www.wikidata.org/wiki/Q5590520","display_name":"Gp41","level":4,"score":0.700508177280426},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.57392418384552},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5467445254325867},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5403125882148743},{"id":"https://openalex.org/C2778190748","wikidata":"https://www.wikidata.org/wiki/Q7907956","display_name":"Vaccine trial","level":3,"score":0.46506765484809875},{"id":"https://openalex.org/C2780195530","wikidata":"https://www.wikidata.org/wiki/Q1479804","display_name":"HIV vaccine","level":4,"score":0.4453151524066925},{"id":"https://openalex.org/C2779690655","wikidata":"https://www.wikidata.org/wiki/Q374232","display_name":"Lentivirus","level":4,"score":0.4204787611961365},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.37234383821487427},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.31793707609176636},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.18080484867095947},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.14401349425315857},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.qai.0000456200.40808.06","doi":"https://doi.org/10.1097/01.qai.0000456200.40808.06","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.qai.0000456200.40808.06","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2144266766","https://openalex.org/W1954577415","https://openalex.org/W2312381581","https://openalex.org/W2793338821","https://openalex.org/W2766647922","https://openalex.org/W2776313920","https://openalex.org/W2019405644","https://openalex.org/W2041403546","https://openalex.org/W7098823006","https://openalex.org/W7097345992"],"abstract_inverted_index":{"Antibody-dependent":[0],"cell-mediated":[1],"cytotoxicity":[2],"(ADCC)":[3],"has":[4],"been":[5],"linked":[6],"to":[7,77,114,132,141],"control":[8],"or":[9,22],"prevention":[10],"of":[11,62,93,105,119,157,166],"HIV-1":[12,89,176],"in":[13,65,145],"natural":[14],"infection,":[15],"the":[16,29,59,120,125,133,160,167],"RV144":[17],"clinical":[18],"trial,":[19],"and":[20,42,53,72,117,149],"SIV":[21],"SHIV":[23],"nonhuman":[24],"primate":[25],"models.":[26],"Env":[27,148,158],"(gp120/gp41),":[28],"only":[30],"viral":[31],"protein":[32],"exposed":[33],"on":[34],"virions":[35],"that":[36,111],"is":[37,82,139,150],"responsible":[38],"for":[39,49,152,175],"cellular":[40],"recognition":[41,154],"cell/virion":[43],"fusion,":[44],"represents":[45],"an":[46,83,88],"important":[47],"target":[48,174],"ADCC":[50,96],"mediating":[51,94],"antibodies":[52],"vaccine":[54,177],"design.":[55,178],"We":[56],"have":[57],"determined":[58],"crystal":[60],"structure":[61,109],"N60-i3":[63,81,106,112,168],"Fab":[64,107],"complex":[66,108],"with":[67,143,159],"clade":[68],"A/E":[69],"gp12093TH057":[70],"coree":[71],"a":[73,172],"CD4-mimetic":[74],"peptide,":[75],"M48U1,":[76],"3.2":[78],"\u00c5":[79],"resolution.":[80],"A32-like":[84],"antibody":[85,153],"derived":[86],"from":[87],"infected":[90],"individual":[91],"capable":[92],"potent":[95],"against":[97],"envelope":[98],"coated":[99],"cells":[100],"and/or":[101],"bound":[102],"virions.":[103],"Analysis":[104],"indicates":[110],"binds":[113],"layers":[115],"1":[116],"2":[118],"gp120":[121,136],"inner":[122],"domain":[123],"within":[124],"C1/C2":[126],"region.":[127],"The":[128],"identified":[129],"epitope":[130,169],"maps":[131],"highly":[134],"conserved":[135],"region":[137],"which":[138],"known":[140],"interact":[142],"gp41":[144],"un-triggered":[146],"trimeric":[147],"inaccessible":[151],"until":[155],"interactions":[156],"host":[161],"receptor":[162],"CD4.":[163],"High":[164],"conservation":[165],"makes":[170],"it":[171],"prime":[173]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}